TWP
IBB icon

Tyche Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History

Tyche Wealth Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$584K Sell
3,071
-30
-1% -$5.16K 0.08% 171
2026
Q1 		$524K Sell
3,101
-470
-13% -$80.4K 0.08% 190
2025
Q4 		$603K Buy
3,571
+275
+8% +$44.7K 0.1% 167
2025
Q3 		$476K Hold
3,296
– – 0.08% 166
2025
Q2 		$417K Sell
3,296
-754
-19% -$92.6K 0.08% 166
2025
Q1 		$518K Sell
4,050
-182
-4% -$24.7K 0.11% 132
2024
Q4 		$560K Sell
4,232
-45
-1% -$6.33K 0.12% 146
2024
Q3 		$623K Sell
4,277
-62
-1% -$8.97K 0.14% 107
2024
Q2 		$596K Sell
4,339
-1,392
-24% -$186K 0.14% 111
2024
Q1 		$786K Sell
5,731
-171
-3% -$23.4K 0.19% 93
2023
Q4 		$802K Buy
+5,902
New +$720K 0.19% 97

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Tyche Wealth Partners's IBB Position: Q2 2026 in Review

Tyche Wealth Partners reduced its iShares Biotechnology ETF (IBB) stake by 0.97% in Q2 2026, selling an estimated $5.16K and leaving 3,071 shares worth $584K. The position accounts for 0.08% of the portfolio, ranked #171.

Tyche Wealth Partners first reported a position in IBB in Q4 2023 and has held it in 11 quarters since. The position peaked at $802K in Q4 2023. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Tyche Wealth Partners held 3,071 shares of iShares Biotechnology ETF worth $584K as of Q2 2026.
  • Tyche Wealth Partners sold 30 iShares Biotechnology ETF shares in Q2 2026, an estimated $5.16K.
  • iShares Biotechnology ETF made up 0.08% of Tyche Wealth Partners's portfolio in Q2 2026, its #171 holding.
  • Tyche Wealth Partners first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 11 quarters since.
  • Tyche Wealth Partners's iShares Biotechnology ETF position peaked at $802K in Q4 2023.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Tyche Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.